DORNASE ALFA

DORNASE ALFA was reported 19633 times

DORNASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMNIOTIC FLUID INDEX INCREASED 13 0.7222
1 CYSTIC FIBROSIS HEPATIC DISEASE 11 0.4783
2 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2316 0.4251
3 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 10 0.4000
4 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 313 0.3505
5 CYSTIC FIBROSIS 1776 0.3205
6 CYSTIC FIBROSIS LUNG 36 0.2812
7 CYSTIC FIBROSIS RELATED DIABETES 32 0.2192
8 DISTAL INTESTINAL OBSTRUCTION SYNDROME 60 0.1780
9 BACTERIAL DISEASE CARRIER 89 0.1221
10 PULMONARY FUNCTION TEST DECREASED 494 0.1127
11 ADVERSE EVENT FOLLOWING IMMUNISATION 6 0.1071
12 SWEAT TEST ABNORMAL 7 0.1029
13 INFECTIVE EXACERBATION OF BRONCHIECTASIS 30 0.0977
14 SPINAL MUSCULAR ATROPHY 25 0.0926
15 BRONCHIAL SECRETION RETENTION 112 0.0879
16 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 6 0.0833
17 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 35 0.0685
18 RESPIRATORY TRACT INFECTION BACTERIAL 33 0.0663
19 BURKHOLDERIA TEST POSITIVE 8 0.0645
20 FORCED EXPIRATORY VOLUME ABNORMAL 9 0.0621
21 PSEUDOMONAS TEST POSITIVE 49 0.0598
22 BRONCHOSCOPY 14 0.0591
23 SPUTUM INCREASED 123 0.0568
24 STOMA CLOSURE 16 0.0514
25 PANCREATIC INSUFFICIENCY 18 0.0503
26 SINUS OPERATION 118 0.0495
27 INCREASED VISCOSITY OF BRONCHIAL SECRETION 31 0.0486
28 FOETAL MACROSOMIA 13 0.0468
29 LUNG INFECTION PSEUDOMONAL 26 0.0466
30 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 43 0.0464
31 SUPERINFECTION 69 0.0460
32 STENOTROPHOMONAS TEST POSITIVE 6 0.0448
33 LEFT-TO-RIGHT CARDIAC SHUNT 13 0.0441
34 PNEUMOCOCCAL SEPSIS 28 0.0426
35 ACHROMOBACTER INFECTION 5 0.0417
36 ATYPICAL MYCOBACTERIUM TEST POSITIVE 4 0.0412
37 FORCED EXPIRATORY VOLUME DECREASED 115 0.0406
38 MOTOR NEURONE DISEASE 19 0.0390
39 PASTEURELLA INFECTION 5 0.0388
40 PSEUDOMONAS INFECTION 326 0.0380
41 POSITIVE AIRWAY PRESSURE THERAPY 11 0.0377
42 POST-TUSSIVE VOMITING 6 0.0368
43 INCREASED BRONCHIAL SECRETION 92 0.0359
44 BURKHOLDERIA CEPACIA COMPLEX INFECTION 10 0.0350
45 LUNG TRANSPLANT 118 0.0333
46 INTERCEPTED PRODUCT STORAGE ERROR 118 0.0330
47 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 24 0.0314
48 NASAL INFLAMMATION 32 0.0303
49 GASTROSTOMY TUBE SITE COMPLICATION 6 0.0300
50 INTERCEPTED MEDICATION ERROR 125 0.0270
51 PNEUMONIA PSEUDOMONAL 41 0.0267
52 PULMONARY FUNCTION TEST ABNORMAL 38 0.0244
53 TRACHEOSTOMY MALFUNCTION 5 0.0242
54 GENITAL CANDIDIASIS 5 0.0235
55 ASPERGILLUS TEST POSITIVE 7 0.0227
56 DISEASE COMPLICATION 102 0.0223
57 RHINOVIRUS INFECTION 86 0.0221
58 STAPHYLOCOCCUS TEST POSITIVE 43 0.0204
59 RESPIRATORY TRACT IRRITATION 21 0.0201
60 FUNGAL TEST POSITIVE 7 0.0199
61 ISCHAEMIC CEREBRAL INFARCTION 23 0.0198
62 CLUBBING 8 0.0196
63 SPUTUM RETENTION 19 0.0192
64 MOTOR DEVELOPMENTAL DELAY 11 0.0190
65 CORONA VIRUS INFECTION 8 0.0186
66 SPUTUM ABNORMAL 12 0.0181
67 ADENOIDECTOMY 7 0.0180
68 SPORTS INJURY 6 0.0174
69 ENTEROVIRUS INFECTION 15 0.0174
70 LUNG INFECTION 268 0.0172
71 SPIROMETRY ABNORMAL 10 0.0167
72 BRONCHIAL DISORDER 26 0.0167
73 HAEMOPTYSIS 464 0.0166
74 PANCREATIC FAILURE 29 0.0164
75 STEATORRHOEA 42 0.0157
76 LOWER RESPIRATORY TRACT INFECTION FUNGAL 6 0.0154
77 MYCOBACTERIUM ABSCESSUS INFECTION 11 0.0154
78 LYMPHADENECTOMY 15 0.0154
79 BRONCHIAL WALL THICKENING 11 0.0153
80 PNEUMONIA STAPHYLOCOCCAL 28 0.0142
81 EMERGENCY CARE 43 0.0142
82 SCOLIOSIS 87 0.0140
83 CROUP INFECTIOUS 11 0.0140
84 LOWER RESPIRATORY TRACT INFECTION VIRAL 7 0.0138
85 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 4 0.0138
86 PARAINFLUENZAE VIRUS INFECTION 21 0.0138
87 RESPIRATORY TRACT INFECTION FUNGAL 7 0.0133
88 BRONCHIECTASIS 89 0.0132
89 CATARACT SUBCAPSULAR 8 0.0131
90 STENOTROPHOMONAS INFECTION 17 0.0125
91 RESPIRATORY SYMPTOM 35 0.0123
92 SINUS POLYP 7 0.0121
93 RESUSCITATION 20 0.0121
94 CULTURE POSITIVE 10 0.0120
95 ATELECTASIS 115 0.0119
96 PULMONARY HAEMORRHAGE 88 0.0112
97 RHONCHI 15 0.0109
98 MYCOTIC ALLERGY 9 0.0105
99 DIAPHRAGMATIC PARALYSIS 6 0.0100
100 DEPENDENCE ON RESPIRATOR 4 0.0100
101 SOCIAL PROBLEM 41 0.0099
102 LUNG CONSOLIDATION 27 0.0096
103 CARBON DIOXIDE INCREASED 13 0.0095
104 CHEST X-RAY ABNORMAL 29 0.0094
105 RESPIRATION ABNORMAL 65 0.0094
106 ANTIBIOTIC THERAPY 9 0.0092
107 TRACHEITIS 7 0.0092
108 LUNG TRANSPLANT REJECTION 6 0.0091
109 HAEMOTHORAX 26 0.0090
110 MECHANICAL VENTILATION 17 0.0089
111 BRONCHOSPASM 124 0.0087
112 HOSPITALISATION 1320 0.0086
113 SPUTUM DISCOLOURED 81 0.0085
114 GASTROSTOMY 13 0.0084
115 PNEUMOTHORAX 130 0.0082
116 RESPIRATORY TRACT INFECTION VIRAL 19 0.0082
117 TOTAL LUNG CAPACITY DECREASED 13 0.0081
118 PRODUCTIVE COUGH 384 0.0080
119 GASTROINTESTINAL TUBE INSERTION 20 0.0080
120 RASH MORBILLIFORM 22 0.0079
121 RUBBER SENSITIVITY 12 0.0078
122 MYCOBACTERIUM AVIUM COMPLEX INFECTION 21 0.0078
123 ACTIVITIES OF DAILY LIVING DECREASED 5 0.0078
124 EXERCISE TOLERANCE DECREASED 45 0.0078
125 TRACHEOBRONCHITIS 6 0.0078
126 CHALAZION 5 0.0078
127 CHRONIC SINUSITIS 29 0.0077
128 RESPIRATORY SYNCYTIAL VIRUS INFECTION 67 0.0077
129 RENAL SURGERY 5 0.0077
130 NASAL POLYPS 37 0.0075
131 SPUTUM CULTURE POSITIVE 6 0.0074
132 CENTRAL VENOUS CATHETERISATION 22 0.0073
133 NONSPECIFIC REACTION 40 0.0073
134 DERMATITIS DIAPER 5 0.0071
135 HEAD BANGING 4 0.0070
136 BLOOD IMMUNOGLOBULIN E INCREASED 17 0.0070
137 MYCOBACTERIAL INFECTION 12 0.0070
138 SECRETION DISCHARGE 86 0.0069
139 PULMONARY PAIN 20 0.0068
140 LUNG DISORDER 333 0.0068
141 ENDOTRACHEAL INTUBATION 19 0.0068
142 TONSILLECTOMY 11 0.0066
143 INFECTION 950 0.0066
144 INTUSSUSCEPTION 6 0.0063
145 PARANASAL SINUS HYPERSECRETION 24 0.0063
146 VITAMIN B12 INCREASED 5 0.0063
147 FORCED VITAL CAPACITY DECREASED 4 0.0061
148 BLOODY DISCHARGE 7 0.0061
149 HAEMOPHILUS INFECTION 6 0.0061
150 DEVICE RELATED THROMBOSIS 6 0.0061
151 LUNG OPERATION 5 0.0060
152 LOWER RESPIRATORY TRACT CONGESTION 10 0.0059
153 SINUS DISORDER 114 0.0058
154 H1N1 INFLUENZA 8 0.0057
155 BRONCHIAL OBSTRUCTION 8 0.0057
156 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 96 0.0056
157 APPENDICECTOMY 20 0.0056
158 UNDERWEIGHT 11 0.0056
159 EMPYEMA 11 0.0055
160 DISTURBANCE IN SOCIAL BEHAVIOUR 13 0.0055
161 GASTROINTESTINAL OBSTRUCTION 13 0.0054
162 BACTERIAL TEST POSITIVE 12 0.0054
163 EOSINOPHIL COUNT ABNORMAL 4 0.0054
164 BRONCHITIS BACTERIAL 4 0.0053
165 LUNG ABSCESS 11 0.0052
166 NO ADVERSE EVENT 944 0.0052
167 GASTROINTESTINAL SURGERY 4 0.0052
168 SINUS PAIN 12 0.0051
169 METAPNEUMOVIRUS INFECTION 4 0.0051
170 STAPHYLOCOCCAL INFECTION 168 0.0051
171 INTESTINAL ISCHAEMIA 28 0.0051
172 PHARYNGITIS STREPTOCOCCAL 55 0.0051
173 CEREBRAL ISCHAEMIA 26 0.0050
174 VIRAL INFECTION 168 0.0050
175 WEIGHT ABNORMAL 12 0.0050
176 VESTIBULAR DISORDER 6 0.0049
177 ASPERGILLUS INFECTION 32 0.0049
178 PNEUMONIA BACTERIAL 44 0.0048
179 SINUSITIS BACTERIAL 5 0.0047
180 ENZYME LEVEL INCREASED 4 0.0047
181 PNEUMONIA VIRAL 15 0.0047
182 DEMYELINATION 19 0.0046
183 RESPIRATORY TRACT CONGESTION 73 0.0046
184 GASTROENTERITIS NOROVIRUS 6 0.0045
185 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19 0.0045
186 PARANASAL SINUS DISCOMFORT 17 0.0045
187 METABOLIC DISORDER 26 0.0045
188 BACTERIAL INFECTION 81 0.0043
189 DRUG SCREEN FALSE POSITIVE 12 0.0043
190 EPIDIDYMITIS 5 0.0043
191 ABNORMAL FAECES 35 0.0043
192 STAPHYLOCOCCAL SEPSIS 21 0.0042
193 HEPATIC NECROSIS 16 0.0042
194 BILE DUCT OBSTRUCTION 8 0.0042
195 VIRAL UPPER RESPIRATORY TRACT INFECTION 20 0.0042
196 DISCOLOURED VOMIT 4 0.0042
197 EOSINOPHILIA 72 0.0041
198 WHEEZING 243 0.0041
199 NASAL SEPTUM DEVIATION 8 0.0041
200 OTITIS EXTERNA 5 0.0041
201 PRODUCT TEMPERATURE EXCURSION ISSUE 21 0.0041
202 MASTOIDITIS 4 0.0041
203 PNEUMONIA 1308 0.0040
204 INFLUENZA 450 0.0040
205 CREPITATIONS 12 0.0040
206 INFECTIOUS MONONUCLEOSIS 9 0.0040
207 RIB FRACTURE 82 0.0040
208 SPEECH DISORDER DEVELOPMENTAL 11 0.0038
209 RESPIRATORY DISORDER 114 0.0038
210 HYPOVITAMINOSIS 5 0.0038
211 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 179 0.0037
212 GLUCOSE TOLERANCE IMPAIRED 22 0.0037
213 VULVOVAGINAL CANDIDIASIS 5 0.0037
214 PULMONARY CONGESTION 48 0.0036
215 LIVER TRANSPLANT 13 0.0036
216 COUGH 1000 0.0036
217 INTESTINAL OBSTRUCTION 134 0.0036
218 LIVER FUNCTION TEST INCREASED 76 0.0035
219 BEHAVIOUR DISORDER 19 0.0035
220 TRACHEOSTOMY 5 0.0035
221 ACUTE SINUSITIS 6 0.0035
222 TERMINAL INSOMNIA 6 0.0034
223 VOLVULUS 8 0.0034
224 TRANSPLANT 8 0.0034
225 CARDIOPULMONARY FAILURE 13 0.0033
226 UPPER RESPIRATORY TRACT INFECTION 154 0.0033
227 TREATMENT NONCOMPLIANCE 182 0.0033
228 OBSTRUCTIVE AIRWAYS DISORDER 37 0.0033
229 ACNE CYSTIC 10 0.0033
230 HYPERCAPNIA 10 0.0033
231 CHRONIC RESPIRATORY FAILURE 4 0.0033
232 BRAIN INJURY 33 0.0033
233 LUNG INFILTRATION 29 0.0033
234 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
235 PORTAL HYPERTENSION 10 0.0032
236 MUCOUS STOOLS 16 0.0032
237 RESPIRATORY TRACT INFECTION 84 0.0032
238 BLOOD UREA DECREASED 4 0.0032
239 SINUS CONGESTION 43 0.0032
240 TESTICULAR PAIN 10 0.0032
241 HEPATIC INFECTION 4 0.0031
242 ANION GAP INCREASED 4 0.0030
243 CHEST DISCOMFORT 303 0.0030
244 PRODUCT STORAGE ERROR 258 0.0029
245 INSURANCE ISSUE 45 0.0029
246 IMPAIRED QUALITY OF LIFE 42 0.0029
247 STREPTOCOCCAL INFECTION 16 0.0029
248 EAR INFECTION 76 0.0029
249 LOWER RESPIRATORY TRACT INFECTION 128 0.0028
250 TACHYPNOEA 38 0.0028
251 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 20 0.0028
252 HORDEOLUM 12 0.0028
253 RALES 16 0.0028
254 OTOTOXICITY 5 0.0027
255 FAECES PALE 6 0.0027
256 LARGE INTESTINAL OBSTRUCTION 6 0.0027
257 IDIOPATHIC INTRACRANIAL HYPERTENSION 6 0.0027
258 NEPHROLITHIASIS 121 0.0026
259 BREATH SOUNDS ABNORMAL 13 0.0026
260 MALNUTRITION 29 0.0026
261 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
262 BLOOD CREATININE DECREASED 8 0.0026
263 MOTOR DYSFUNCTION 26 0.0025
264 ACUTE RESPIRATORY FAILURE 49 0.0025
265 RED BLOOD CELL COUNT INCREASED 7 0.0025
266 EOSINOPHIL COUNT INCREASED 21 0.0025
267 APHONIA 35 0.0025
268 PAINFUL RESPIRATION 6 0.0025
269 ILL-DEFINED DISORDER 149 0.0025
270 CHANGE OF BOWEL HABIT 5 0.0024
271 UPPER-AIRWAY COUGH SYNDROME 20 0.0024
272 SINUSITIS 246 0.0024
273 OBSESSIVE-COMPULSIVE DISORDER 19 0.0024
274 INCORRECT PRODUCT STORAGE 31 0.0024
275 GASTRIC INFECTION 9 0.0024
276 LAZINESS 4 0.0023
277 INJECTION SITE OEDEMA 4 0.0023
278 BLOOD CHLORIDE INCREASED 4 0.0023
279 VENTRICULAR DYSFUNCTION 6 0.0023
280 DYSPHONIA 132 0.0023
281 GAMMA-GLUTAMYLTRANSFERASE INCREASED 50 0.0023
282 JUGULAR VEIN THROMBOSIS 4 0.0022
283 LIVER TRANSPLANT REJECTION 4 0.0022
284 ASPARTATE AMINOTRANSFERASE INCREASED 118 0.0022
285 PAPILLOEDEMA 10 0.0022
286 BILE DUCT STONE 7 0.0022
287 INCREASED APPETITE 42 0.0022
288 CHOLECYSTECTOMY 25 0.0022
289 SINUS HEADACHE 13 0.0022
290 ALANINE AMINOTRANSFERASE INCREASED 133 0.0022
291 SERUM SICKNESS 6 0.0022
292 MENOPAUSAL SYMPTOMS 5 0.0021
293 SELF-INJURIOUS IDEATION 9 0.0021
294 BILIRUBIN CONJUGATED INCREASED 5 0.0021
295 RENAL TUBULAR DISORDER 6 0.0021
296 VITILIGO 5 0.0021
297 PROTEIN TOTAL DECREASED 8 0.0021
298 CHOLECYSTITIS ACUTE 12 0.0021
299 MALABSORPTION 11 0.0021
300 PRE-ECLAMPSIA 10 0.0021
301 OXYGEN CONSUMPTION INCREASED 5 0.0021
302 NASOPHARYNGITIS 384 0.0021
303 ADENOVIRUS INFECTION 6 0.0021
304 PRODUCT DOSE OMISSION 135 0.0021
305 DRY THROAT 21 0.0021
306 RESPIRATORY DISTRESS 57 0.0021
307 OXYGEN SATURATION DECREASED 116 0.0021
308 CONDITION AGGRAVATED 623 0.0020
309 DECREASED INTEREST 12 0.0020
310 PNEUMONIA FUNGAL 8 0.0020
311 DEPRESSIVE SYMPTOM 7 0.0020
312 AGGRESSION 99 0.0020
313 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
314 SLEEP DISORDER 139 0.0020
315 CORONAVIRUS INFECTION 13 0.0020
316 RESPIRATORY FAILURE 143 0.0020
317 NASAL CONGESTION 115 0.0020
318 GASTROENTERITIS VIRAL 35 0.0019
319 ASTHMA 218 0.0019
320 CATHETER SITE PAIN 5 0.0019
321 RESPIRATORY RATE DECREASED 6 0.0019
322 MUSCLE ATROPHY 24 0.0019
323 CIRCULATORY COLLAPSE 32 0.0019
324 HEPATIC ENZYME INCREASED 128 0.0019
325 SMALL INTESTINAL OBSTRUCTION 23 0.0019
326 IMPULSIVE BEHAVIOUR 7 0.0019
327 JAW FRACTURE 4 0.0019
328 BLOOD BILIRUBIN INCREASED 50 0.0018
329 HENOCH-SCHONLEIN PURPURA 4 0.0018
330 ILLNESS 188 0.0018
331 SUSPECTED COVID-19 6 0.0018
332 WEIGHT FLUCTUATION 19 0.0018
333 RESPIRATORY RATE INCREASED 16 0.0018
334 RHINITIS ALLERGIC 8 0.0018
335 GASTROINTESTINAL DISORDER 158 0.0018
336 HYPERPHAGIA 7 0.0018
337 INCREASED UPPER AIRWAY SECRETION 9 0.0018
338 RHINORRHOEA 111 0.0017
339 GROWTH RETARDATION 5 0.0017
340 PNEUMONIA ASPIRATION 42 0.0017
341 SLEEP TERROR 7 0.0017
342 AFFECTIVE DISORDER 13 0.0017
343 LYMPHADENITIS 4 0.0017
344 BRONCHITIS CHRONIC 4 0.0016
345 DYSPNOEA 926 0.0016
346 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
347 GASTROINTESTINAL SOUNDS ABNORMAL 8 0.0016
348 INTENTIONAL DOSE OMISSION 46 0.0016
349 DEVICE INFUSION ISSUE 4 0.0016
350 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
351 INTENTIONAL PRODUCT USE ISSUE 140 0.0016
352 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
353 INFUSION SITE PRURITUS 5 0.0016
354 NON-CARDIAC CHEST PAIN 5 0.0016
355 APPENDICITIS PERFORATED 4 0.0016
356 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
357 HERNIA REPAIR 4 0.0015
358 BREAST ENLARGEMENT 5 0.0015
359 SURGERY 89 0.0015
360 LUNG OPACITY 4 0.0015
361 MENTAL DISORDER 66 0.0015
362 FLATULENCE 86 0.0015
363 RENAL FUNCTION TEST ABNORMAL 7 0.0015
364 ABDOMINAL PAIN UPPER 309 0.0015
365 ANXIETY DISORDER 5 0.0015
366 DEPRESSED MOOD 79 0.0015
367 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
368 FAECALOMA 8 0.0015
369 HEPATIC FIBROSIS 5 0.0015
370 PREGNANCY 29 0.0014
371 POLYMENORRHOEA 5 0.0014
372 FUNGAL INFECTION 48 0.0014
373 HYPERTRANSAMINASAEMIA 10 0.0014
374 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 102 0.0014
375 MUSCLE FATIGUE 6 0.0014
376 MOOD SWINGS 45 0.0014
377 HEPATIC ENZYME ABNORMAL 7 0.0014
378 MIDDLE INSOMNIA 26 0.0014
379 POOR QUALITY DRUG ADMINISTERED 9 0.0014
380 DYSPNOEA AT REST 4 0.0014
381 BILIARY COLIC 4 0.0014
382 POLYP 9 0.0014
383 OROPHARYNGEAL PAIN 127 0.0014
384 MUSCULOSKELETAL CHEST PAIN 21 0.0014
385 EXPOSURE DURING PREGNANCY 84 0.0014
386 PANCREATITIS 71 0.0013
387 PROTHROMBIN TIME PROLONGED 8 0.0013
388 ATYPICAL PNEUMONIA 4 0.0013
389 ESCHERICHIA INFECTION 11 0.0013
390 VASCULAR DEVICE INFECTION 6 0.0013
391 PYREXIA 457 0.0013
392 COMPLICATION ASSOCIATED WITH DEVICE 19 0.0013
393 ANGER 44 0.0013
394 FIBROSIS 4 0.0013
395 ASCITES 38 0.0013
396 SARS-COV-2 TEST POSITIVE 17 0.0013
397 APPENDICITIS 12 0.0013
398 MOOD ALTERED 35 0.0013
399 BRAIN FOG 20 0.0013
400 HAND FRACTURE 9 0.0013
401 IDIOPATHIC PULMONARY FIBROSIS 5 0.0013
402 INTRACRANIAL PRESSURE INCREASED 7 0.0013
403 BLOOD UREA INCREASED 21 0.0013
404 APHAGIA 6 0.0012
405 CONJUNCTIVITIS 23 0.0012
406 PREMATURE LABOUR 7 0.0012
407 GALLBLADDER OPERATION 5 0.0012
408 RESPIRATORY ARREST 34 0.0012
409 VITAMIN D DEFICIENCY 12 0.0012
410 HORMONE LEVEL ABNORMAL 6 0.0012
411 HYPOVENTILATION 4 0.0012
412 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
413 BODY TEMPERATURE DECREASED 12 0.0012
414 PANCREATIC DISORDER 6 0.0012
415 HYPERVOLAEMIA 6 0.0012
416 BLOOD TEST ABNORMAL 17 0.0012
417 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
418 PHARYNGITIS 15 0.0012
419 MENSTRUAL DISORDER 10 0.0012
420 OVARIAN CYST 12 0.0012
421 HYPOXIA 42 0.0012
422 ASPIRATION 13 0.0012
423 ENERGY INCREASED 7 0.0012
424 PRODUCT DISTRIBUTION ISSUE 11 0.0012
425 DEAFNESS 31 0.0012
426 CANDIDA INFECTION 20 0.0012
427 THROAT IRRITATION 53 0.0012
428 HEPATIC STEATOSIS 22 0.0012
429 BOWEL MOVEMENT IRREGULARITY 9 0.0012
430 LIVER DISORDER 52 0.0012
431 BRONCHOPNEUMONIA 4 0.0012
432 WEIGHT DECREASED 326 0.0012
433 TYPE 1 DIABETES MELLITUS 7 0.0012
434 FAILURE TO THRIVE 6 0.0012
435 OCULAR ICTERUS 5 0.0012
436 HYPOPNOEA 4 0.0012
437 CHAPPED LIPS 5 0.0012
438 COVID-19 202 0.0012
439 HEART RATE INCREASED 114 0.0011
440 TONSILLITIS 6 0.0011
441 BRONCHITIS 85 0.0011
442 ORAL CANDIDIASIS 15 0.0011
443 HEPATIC CIRRHOSIS 21 0.0011
444 OFF LABEL USE 975 0.0011
445 DEVICE RELATED INFECTION 17 0.0011
446 TIC 6 0.0011
447 EAR DISORDER 5 0.0011
448 AUTISM SPECTRUM DISORDER 6 0.0011
449 WEIGHT INCREASED 243 0.0011
450 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
451 MALAISE 473 0.0011
452 BODY TEMPERATURE INCREASED 22 0.0011
453 CONSTIPATION 235 0.0011
454 INITIAL INSOMNIA 11 0.0011
455 ANXIETY 305 0.0011
456 BLOOD SODIUM DECREASED 20 0.0011
457 APPETITE DISORDER 7 0.0011
458 CHEST PAIN 195 0.0011
459 VITAMIN D DECREASED 9 0.0011
460 CARDIAC FAILURE ACUTE 7 0.0010
461 THERAPY INTERRUPTED 75 0.0010
462 GESTATIONAL DIABETES 5 0.0010
463 TINNITUS 48 0.0010
464 CLAVICLE FRACTURE 4 0.0010
465 INTENTIONAL SELF-INJURY 21 0.0010
466 CONCUSSION 8 0.0010
467 THERAPY CESSATION 53 0.0010
468 PHOTOSENSITIVITY REACTION 17 0.0010
469 BLOOD GLUCOSE ABNORMAL 19 0.0010
470 FAECES HARD 4 0.0010
471 INFLAMMATION 53 0.0010
472 ABNORMAL LOSS OF WEIGHT 7 0.0010
473 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
474 GASTRIC DISORDER 35 0.0010
475 DECREASED ACTIVITY 11 0.0010
476 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
477 HEPATOMEGALY 10 0.0010
478 ABDOMINAL DISTENSION 106 0.0010
479 ABDOMINAL PAIN 235 0.0010
480 ABDOMINAL TENDERNESS 5 0.0010
481 ANEURYSM 5 0.0010
482 FRUSTRATION TOLERANCE DECREASED 8 0.0010
483 TRANSAMINASES INCREASED 22 0.0010
484 SEASONAL ALLERGY 14 0.0010
485 ADRENAL INSUFFICIENCY 12 0.0010
486 TOE AMPUTATION 5 0.0010
487 DEPRESSION 223 0.0010
488 CHOLELITHIASIS 32 0.0010
489 CHROMATURIA 22 0.0010
490 CYANOSIS 15 0.0010
491 UPPER LIMB FRACTURE 19 0.0010
492 SUICIDAL IDEATION 87 0.0009
493 BRAIN OEDEMA 12 0.0009
494 SCREAMING 6 0.0009
495 PULMONARY MASS 14 0.0009
496 RASH PAPULAR 21 0.0009
497 FOOD POISONING 5 0.0009
498 DEHYDRATION 124 0.0009
499 PAROSMIA 7 0.0009
500 WRIST FRACTURE 11 0.0009
501 KIDNEY INFECTION 18 0.0009
502 MANIA 15 0.0009
503 DRUG INTOLERANCE 88 0.0009
504 GENERAL PHYSICAL HEALTH DETERIORATION 105 0.0009
505 TENDONITIS 14 0.0009
506 IRRITABILITY 54 0.0009
507 HEART RATE ABNORMAL 5 0.0009
508 GALLBLADDER DISORDER 16 0.0009
509 IRON DEFICIENCY 4 0.0009
510 INFLUENZA LIKE ILLNESS 73 0.0009
511 COLECTOMY 5 0.0009
512 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
513 PRODUCT DOSE OMISSION IN ERROR 25 0.0009
514 BLOOD ALBUMIN DECREASED 7 0.0009
515 MIGRAINE 84 0.0009
516 HAEMOGLOBIN INCREASED 4 0.0009
517 EMOTIONAL DISORDER 27 0.0009
518 HEADACHE 548 0.0009
519 HYPOGLYCAEMIA 42 0.0009
520 DYSPEPSIA 85 0.0009
521 ARTHRITIS INFECTIVE 4 0.0009
522 PERSONALITY CHANGE 8 0.0009
523 ELECTROLYTE IMBALANCE 10 0.0009
524 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 29 0.0009
525 RASH MACULO-PAPULAR 19 0.0009
526 BLOOD GLUCOSE DECREASED 41 0.0009
527 ENDOMETRIOSIS 4 0.0008
528 HYPERSOMNIA 24 0.0008
529 POST PROCEDURAL COMPLICATION 16 0.0008
530 DRUG-INDUCED LIVER INJURY 26 0.0008
531 PULMONARY THROMBOSIS 9 0.0008
532 SEIZURE 95 0.0008
533 GASTROOESOPHAGEAL REFLUX DISEASE 66 0.0008
534 SEPSIS 91 0.0008
535 CARDIAC OPERATION 7 0.0008
536 PSYCHIATRIC SYMPTOM 6 0.0008
537 LIGAMENT SPRAIN 8 0.0008
538 ABNORMAL BEHAVIOUR 32 0.0008
539 SNEEZING 18 0.0008
540 NEPHROPATHY TOXIC 9 0.0008
541 DRY EYE 40 0.0008
542 PANCREATITIS ACUTE 18 0.0008
543 NASAL DRYNESS 5 0.0008
544 STATUS EPILEPTICUS 9 0.0008
545 INFUSION SITE SWELLING 5 0.0008
546 RASH PRURITIC 43 0.0008
547 ABDOMINAL DISCOMFORT 132 0.0008
548 SLUGGISHNESS 8 0.0008
549 LIPASE INCREASED 6 0.0008
550 HAEMOLYTIC ANAEMIA 7 0.0008
551 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
552 DRUG DOSE OMISSION 128 0.0008
553 LIMB INJURY 21 0.0008
554 FOETAL DEATH 4 0.0008
555 DECREASED APPETITE 179 0.0008
556 DYSPNOEA EXERTIONAL 29 0.0008
557 SPLENOMEGALY 9 0.0008
558 COVID-19 PNEUMONIA 9 0.0008
559 BLOOD LACTIC ACID INCREASED 4 0.0008
560 RENAL PAIN 8 0.0008
561 RASH ERYTHEMATOUS 36 0.0008
562 MATERNAL EXPOSURE DURING PREGNANCY 67 0.0008
563 EATING DISORDER 16 0.0008
564 HEPATIC ENCEPHALOPATHY 7 0.0007
565 DIABETES MELLITUS 57 0.0007
566 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
567 MYALGIA 127 0.0007
568 POST-TRAUMATIC STRESS DISORDER 5 0.0007
569 RHINITIS 6 0.0007
570 POSTOPERATIVE WOUND INFECTION 5 0.0007
571 ACNE 56 0.0007
572 POST PROCEDURAL INFECTION 6 0.0007
573 SKIN LACERATION 8 0.0007
574 PALPITATIONS 86 0.0007
575 DRUG ERUPTION 13 0.0007
576 IMPAIRED GASTRIC EMPTYING 10 0.0007
577 SPINAL OPERATION 9 0.0007
578 BLOOD GLUCOSE FLUCTUATION 8 0.0007
579 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
580 GENERALISED OEDEMA 9 0.0007
581 ILEUS 9 0.0007
582 EPISTAXIS 54 0.0007
583 LARGE INTESTINE PERFORATION 5 0.0007
584 PHARYNGEAL SWELLING 7 0.0007
585 MENORRHAGIA 14 0.0007
586 THERAPY CHANGE 7 0.0007
587 BLOOD CALCIUM DECREASED 8 0.0007
588 THERMAL BURN 5 0.0007
589 UNEVALUABLE EVENT 53 0.0007
590 PRODUCT DOSE OMISSION ISSUE 205 0.0007
591 RASH GENERALISED 18 0.0007
592 NIGHTMARE 24 0.0007
593 MUSCLE STRAIN 6 0.0007
594 PREMATURE DELIVERY 11 0.0007
595 HYPERVENTILATION 4 0.0007
596 ATRIAL FIBRILLATION 67 0.0007
597 CRYING 25 0.0007
598 HYPERGLYCAEMIA 25 0.0007
599 NEUTROPHIL COUNT INCREASED 7 0.0007
600 GROIN PAIN 6 0.0007
601 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
602 ARTHROPOD BITE 5 0.0007
603 ABORTION SPONTANEOUS 27 0.0007
604 HAEMATEMESIS 17 0.0007
605 GASTROINTESTINAL INFECTION 6 0.0007
606 HYPOPHAGIA 17 0.0007
607 DRUG LEVEL INCREASED 11 0.0007
608 HEPATITIS CHOLESTATIC 4 0.0007
609 PANIC ATTACK 24 0.0007
610 DERMATITIS ACNEIFORM 4 0.0007
611 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 12 0.0007
612 ACIDOSIS 5 0.0007
613 FOOD ALLERGY 5 0.0006
614 CHOLANGITIS 4 0.0006
615 INFUSION SITE EXTRAVASATION 4 0.0006
616 VOMITING 301 0.0006
617 FLANK PAIN 6 0.0006
618 BLOOD PRESSURE INCREASED 97 0.0006
619 DRUG INTERACTION 100 0.0006
620 PNEUMONITIS 17 0.0006
621 SKIN INFECTION 7 0.0006
622 RHABDOMYOLYSIS 26 0.0006
623 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
624 EYE INFECTION 7 0.0006
625 FATIGUE 475 0.0006
626 URTICARIA 102 0.0006
627 INSOMNIA 162 0.0006
628 HAEMATOCRIT DECREASED 12 0.0006
629 OSTEOPENIA 9 0.0006
630 FREQUENT BOWEL MOVEMENTS 16 0.0006
631 FEEDING DISORDER 12 0.0006
632 THROAT TIGHTNESS 16 0.0006
633 NIGHT SWEATS 19 0.0006
634 CATARACT 35 0.0006
635 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
636 RASH 254 0.0006
637 HYPERBILIRUBINAEMIA 6 0.0006
638 INTERSTITIAL LUNG DISEASE 28 0.0006
639 AUTOIMMUNE HEPATITIS 4 0.0006
640 PRODUCT ODOUR ABNORMAL 6 0.0006
641 HYPERSENSITIVITY 106 0.0006
642 DEFAECATION URGENCY 4 0.0006
643 GASTRITIS 15 0.0006
644 DEATH 491 0.0006
645 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
646 EXTRA DOSE ADMINISTERED 23 0.0006
647 DIALYSIS 8 0.0006
648 TACHYCARDIA 50 0.0006
649 OROPHARYNGEAL DISCOMFORT 5 0.0006
650 FAECES DISCOLOURED 12 0.0006
651 BIPOLAR DISORDER 6 0.0006
652 PALLOR 15 0.0006
653 FAECES SOFT 4 0.0005
654 C-REACTIVE PROTEIN INCREASED 20 0.0005
655 DIARRHOEA 354 0.0005
656 MAJOR DEPRESSION 4 0.0005
657 HEPATITIS 14 0.0005
658 GASTROINTESTINAL PAIN 6 0.0005
659 FEELING DRUNK 4 0.0005
660 DYSPHAGIA 51 0.0005
661 MENTAL IMPAIRMENT 13 0.0005
662 ERYTHEMA MULTIFORME 5 0.0005
663 HYPOACUSIS 23 0.0005
664 FOOT FRACTURE 10 0.0005
665 DERMATITIS CONTACT 6 0.0005
666 ROAD TRAFFIC ACCIDENT 22 0.0005
667 INTERNAL HAEMORRHAGE 6 0.0005
668 PARANOIA 9 0.0005
669 MULTI-ORGAN FAILURE 9 0.0005
670 AFFECT LABILITY 5 0.0005
671 HERNIA 10 0.0005
672 RETCHING 11 0.0005
673 LIVER FUNCTION TEST ABNORMAL 15 0.0005
674 CAESAREAN SECTION 6 0.0005
675 HYPOALBUMINAEMIA 4 0.0005
676 EAR PAIN 10 0.0005
677 THROMBOTIC MICROANGIOPATHY 5 0.0005
678 CHOKING 10 0.0005
679 POOR QUALITY SLEEP 11 0.0005
680 PRODUCT USE IN UNAPPROVED INDICATION 126 0.0005
681 BLOOD CREATININE INCREASED 33 0.0005
682 LETHARGY 29 0.0005
683 CHOLECYSTITIS 6 0.0005
684 HALLUCINATION, AUDITORY 8 0.0005
685 HUNGER 7 0.0005
686 FEELING ABNORMAL 120 0.0005
687 PRODUCT USE ISSUE 94 0.0005
688 LEUKOCYTOSIS 9 0.0005
689 ASPHYXIA 4 0.0005
690 ANAPHYLACTIC REACTION 27 0.0005
691 INJURY 34 0.0005
692 EYE DISCHARGE 5 0.0005
693 DERMATITIS ALLERGIC 6 0.0005
694 PLEURAL EFFUSION 29 0.0005
695 INFUSION SITE ERYTHEMA 4 0.0005
696 RENAL DISORDER 22 0.0005
697 FLUID RETENTION 24 0.0005
698 HEPATIC CYTOLYSIS 6 0.0005
699 IMMUNODEFICIENCY 7 0.0005
700 DRUG PRESCRIBING ERROR 9 0.0005
701 INTENTIONAL PRODUCT MISUSE 41 0.0005
702 INFUSION SITE PAIN 6 0.0005
703 BLOOD MAGNESIUM DECREASED 4 0.0005
704 NAUSEA 365 0.0005
705 BACK INJURY 5 0.0005
706 ADVERSE DRUG REACTION 41 0.0005
707 PULMONARY EMBOLISM 43 0.0005
708 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
709 DENTAL CARIES 5 0.0005
710 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
711 MEMORY IMPAIRMENT 62 0.0005
712 HAEMORRHAGE 47 0.0004
713 SWELLING FACE 29 0.0004
714 DISTURBANCE IN ATTENTION 24 0.0004
715 PRODUCT AVAILABILITY ISSUE 10 0.0004
716 ABDOMINAL PAIN LOWER 11 0.0004
717 IRON DEFICIENCY ANAEMIA 4 0.0004
718 GRAND MAL CONVULSION 4 0.0004
719 HEPATIC FAILURE 13 0.0004
720 BLOOD POTASSIUM INCREASED 7 0.0004
721 DRUG RESISTANCE 11 0.0004
722 MOUTH ULCERATION 9 0.0004
723 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
724 DISCOMFORT 26 0.0004
725 PHOTOPHOBIA 8 0.0004
726 BACTERAEMIA 5 0.0004
727 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
728 LIP SWELLING 14 0.0004
729 SKIN DISORDER 14 0.0004
730 ERUCTATION 8 0.0004
731 SUICIDE ATTEMPT 25 0.0004
732 AUTOIMMUNE DISORDER 4 0.0004
733 COELIAC DISEASE 4 0.0004
734 HOSPICE CARE 4 0.0004
735 BLOOD PRESSURE ABNORMAL 8 0.0004
736 RASH MACULAR 14 0.0004
737 AMNESIA 26 0.0004
738 DISEASE PROGRESSION 47 0.0004
739 PRODUCT ADMINISTRATION ERROR 8 0.0004
740 THIRST 7 0.0004
741 SEPTIC SHOCK 17 0.0004
742 EUPHORIC MOOD 4 0.0004
743 PHARYNGEAL OEDEMA 6 0.0004
744 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
745 HELICOBACTER INFECTION 4 0.0004
746 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
747 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
748 FOLLICULITIS 4 0.0004
749 HEAD INJURY 12 0.0004
750 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
751 MUSCULAR WEAKNESS 43 0.0004
752 PRODUCT PRESCRIBING ERROR 9 0.0004
753 MEDICATION ERROR 21 0.0004
754 DYSMENORRHOEA 5 0.0004
755 DIZZINESS 186 0.0004
756 ACUTE KIDNEY INJURY 57 0.0004
757 PRODUCT TASTE ABNORMAL 5 0.0004
758 FEELING JITTERY 7 0.0004
759 LIVER INJURY 9 0.0004
760 ENCEPHALOPATHY 9 0.0004
761 ACUTE HEPATIC FAILURE 5 0.0004
762 PREMATURE BABY 11 0.0004
763 LACRIMATION INCREASED 11 0.0004
764 RENAL FAILURE 48 0.0004
765 BLOOD PRESSURE DECREASED 24 0.0004
766 FALL 120 0.0004
767 MENTAL STATUS CHANGES 10 0.0004
768 PAIN 220 0.0004
769 PULMONARY OEDEMA 16 0.0004
770 EYE PRURITUS 12 0.0004
771 INTESTINAL PERFORATION 4 0.0004
772 HEMIPARESIS 6 0.0004
773 AGITATION 26 0.0004
774 HAEMATURIA 12 0.0004
775 THROMBOSIS 28 0.0003
776 MUSCLE TWITCHING 8 0.0003
777 ANOSMIA 5 0.0003
778 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
779 HAEMATOCHEZIA 19 0.0003
780 GASTROENTERITIS 5 0.0003
781 AMENORRHOEA 6 0.0003
782 HEART RATE DECREASED 12 0.0003
783 BACK PAIN 79 0.0003
784 LYMPHOCYTE COUNT DECREASED 6 0.0003
785 PSYCHOTIC DISORDER 10 0.0003
786 GOUT 6 0.0003
787 HOT FLUSH 25 0.0003
788 TOOTHACHE 6 0.0003
789 APHASIA 10 0.0003
790 HAEMOGLOBIN DECREASED 34 0.0003
791 RESTLESS LEGS SYNDROME 6 0.0003
792 JOINT INJURY 7 0.0003
793 SKIN DISCOLOURATION 15 0.0003
794 ABNORMAL DREAMS 9 0.0003
795 DRUG ADMINISTRATION ERROR 10 0.0003
796 CHILLS 38 0.0003
797 FEELING COLD 9 0.0003
798 THINKING ABNORMAL 6 0.0003
799 HEPATIC FUNCTION ABNORMAL 12 0.0003
800 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
801 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
802 STEVENS-JOHNSON SYNDROME 7 0.0003
803 SENSORY DISTURBANCE 5 0.0003
804 RENAL IMPAIRMENT 26 0.0003
805 HIATUS HERNIA 4 0.0003
806 BLOOD GLUCOSE INCREASED 58 0.0003
807 JOINT STIFFNESS 8 0.0003
808 ASTHENIA 114 0.0003
809 PERICARDIAL EFFUSION 7 0.0003
810 BLISTER 17 0.0003
811 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
812 CYTOMEGALOVIRUS INFECTION 5 0.0003
813 MENSTRUATION IRREGULAR 8 0.0003
814 JOINT SWELLING 36 0.0003
815 FACE OEDEMA 5 0.0003
816 VERTIGO 18 0.0003
817 SCAR 5 0.0003
818 NERVOUS SYSTEM DISORDER 9 0.0003
819 PRESYNCOPE 7 0.0003
820 NEURALGIA 7 0.0003
821 ARTHROPATHY 16 0.0003
822 URINARY TRACT INFECTION 49 0.0003
823 SPEECH DISORDER 15 0.0003
824 PERIPHERAL SWELLING 44 0.0003
825 LYMPHADENOPATHY 10 0.0003
826 HEPATOCELLULAR INJURY 4 0.0003
827 ALOPECIA 55 0.0003
828 HIP FRACTURE 9 0.0003
829 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
830 FEELING HOT 17 0.0003
831 RESTLESSNESS 10 0.0003
832 ARTHRALGIA 113 0.0003
833 EYE SWELLING 10 0.0003
834 SOMNOLENCE 54 0.0003
835 SWELLING 25 0.0003
836 BLOOD POTASSIUM DECREASED 8 0.0003
837 HYPERHIDROSIS 34 0.0003
838 BLOOD COUNT ABNORMAL 4 0.0003
839 BLOOD URINE PRESENT 5 0.0003
840 GASTRIC ULCER 5 0.0003
841 PROTEINURIA 5 0.0003
842 EPILEPSY 8 0.0003
843 LOWER LIMB FRACTURE 5 0.0003
844 JAUNDICE 7 0.0003
845 RENAL FAILURE ACUTE 11 0.0003
846 HYPERKALAEMIA 9 0.0003
847 OCULAR HYPERAEMIA 12 0.0003
848 VISION BLURRED 34 0.0002
849 PAIN IN JAW 7 0.0002
850 COAGULOPATHY 4 0.0002
851 PULMONARY HYPERTENSION 5 0.0002
852 OEDEMA 13 0.0002
853 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
854 HYPOKALAEMIA 11 0.0002
855 PARAESTHESIA 37 0.0002
856 VISUAL IMPAIRMENT 29 0.0002
857 DEEP VEIN THROMBOSIS 15 0.0002
858 EYE PAIN 13 0.0002
859 CARDIAC ARREST 19 0.0002
860 PRODUCT DISPENSING ERROR 5 0.0002
861 ANHEDONIA 6 0.0002
862 GYNAECOMASTIA 7 0.0002
863 LIMB DISCOMFORT 7 0.0002
864 HEAD DISCOMFORT 4 0.0002
865 NEOPLASM MALIGNANT 15 0.0002
866 CARDIAC DISORDER 21 0.0002
867 ISCHAEMIC STROKE 4 0.0002
868 FEAR 6 0.0002
869 BONE PAIN 13 0.0002
870 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
871 PRURITUS 85 0.0002
872 METABOLIC ACIDOSIS 7 0.0002
873 PROCEDURAL PAIN 6 0.0002
874 WOUND 6 0.0002
875 COLITIS 8 0.0002
876 SYNCOPE 21 0.0002
877 RED BLOOD CELL COUNT DECREASED 6 0.0002
878 DIABETIC KETOACIDOSIS 5 0.0002
879 DYSGEUSIA 15 0.0002
880 DISORIENTATION 8 0.0002
881 MUSCLE SPASMS 37 0.0002
882 THERAPY NON-RESPONDER 9 0.0002
883 CONTUSION 19 0.0002
884 DRY MOUTH 16 0.0002
885 ERYTHEMA 40 0.0002
886 KNEE ARTHROPLASTY 4 0.0002
887 HALLUCINATION, VISUAL 4 0.0002
888 NEUROPATHY PERIPHERAL 18 0.0002
889 COMA 9 0.0002
890 CYSTITIS 6 0.0002
891 IRRITABLE BOWEL SYNDROME 4 0.0002
892 PAIN OF SKIN 5 0.0002
893 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
894 HYPERTENSION 39 0.0002
895 PAIN IN EXTREMITY 54 0.0002
896 MELAENA 4 0.0002
897 TREATMENT FAILURE 15 0.0002
898 TREMOR 30 0.0002
899 DRY SKIN 24 0.0002
900 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
901 CELLULITIS 9 0.0002
902 DRUG INEFFECTIVE 235 0.0002
903 ARTHRITIS 14 0.0002
904 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
905 PRODUCT SUBSTITUTION ISSUE 10 0.0002
906 ADVERSE EVENT 16 0.0002
907 DELIRIUM 6 0.0002
908 NERVOUSNESS 9 0.0002
909 ECZEMA 9 0.0002
910 LOSS OF CONSCIOUSNESS 22 0.0002
911 OSTEOPOROSIS 7 0.0002
912 LABORATORY TEST ABNORMAL 5 0.0002
913 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
914 FLUSHING 17 0.0002
915 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
916 LOCALISED INFECTION 4 0.0002
917 CEREBRAL INFARCTION 4 0.0002
918 PRODUCT QUALITY ISSUE 22 0.0002
919 ABASIA 4 0.0002
920 VAGINAL HAEMORRHAGE 7 0.0002
921 NECK PAIN 9 0.0002
922 AGEUSIA 4 0.0002
923 MUSCULOSKELETAL STIFFNESS 14 0.0002
924 DYSARTHRIA 6 0.0002
925 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
926 GAIT DISTURBANCE 30 0.0002
927 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
928 OEDEMA PERIPHERAL 19 0.0002
929 LACTIC ACIDOSIS 5 0.0002
930 IMPAIRED HEALING 5 0.0002
931 EYE DISORDER 5 0.0002
932 BRADYCARDIA 8 0.0002
933 EXPIRED PRODUCT ADMINISTERED 5 0.0002
934 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
935 HYPOAESTHESIA 22 0.0001
936 ANAEMIA 28 0.0001
937 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
938 HYPOTENSION 29 0.0001
939 POLLAKIURIA 6 0.0001
940 WITHDRAWAL SYNDROME 6 0.0001
941 BURNING SENSATION 10 0.0001
942 SKIN EXFOLIATION 12 0.0001
943 HYPONATRAEMIA 8 0.0001
944 DEVICE DISLOCATION 6 0.0001
945 CONFUSIONAL STATE 22 0.0001
946 CHRONIC KIDNEY DISEASE 10 0.0001
947 BONE DENSITY DECREASED 4 0.0001
948 BALANCE DISORDER 11 0.0001
949 CARDIAC FAILURE 10 0.0001
950 CEREBROVASCULAR ACCIDENT 21 0.0001
951 UNDERDOSE 9 0.0001
952 DEVICE BREAKAGE 5 0.0001
953 BLINDNESS 5 0.0001
954 DEVICE ISSUE 11 0.0001
955 CONVULSION 7 0.0001
956 CARDIO-RESPIRATORY ARREST 5 0.0001
957 INJECTION SITE PRURITUS 8 0.0001
958 HALLUCINATION 9 0.0001
959 RECTAL HAEMORRHAGE 5 0.0001
960 STOMATITIS 7 0.0001
961 MUSCULOSKELETAL PAIN 6 0.0001
962 CARDIAC FAILURE CONGESTIVE 9 0.0001
963 NEUTROPENIA 15 0.0001
964 SKIN IRRITATION 5 0.0001
965 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
966 THROMBOCYTOPENIA 12 0.0001
967 INFUSION RELATED REACTION 7 0.0001
968 HERPES ZOSTER 6 0.0001
969 EYE IRRITATION 6 0.0001
970 PLATELET COUNT DECREASED 11 0.0001
971 INCORRECT DOSE ADMINISTERED 23 0.0001
972 DEVICE MALFUNCTION 7 0.0001
973 EMOTIONAL DISTRESS 12 0.0001
974 THERAPEUTIC RESPONSE DECREASED 6 0.0001
975 MOBILITY DECREASED 7 0.0001
976 OVERDOSE 21 0.0001
977 COMPLETED SUICIDE 8 0.0001
978 INJECTION SITE SWELLING 7 0.0001
979 ANGIOEDEMA 4 0.0001
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
981 COGNITIVE DISORDER 4 0.0001
982 ARRHYTHMIA 4 0.0001
983 DERMATITIS ATOPIC 4 0.0001
984 DRUG EFFECT DECREASED 4 0.0001
985 SKIN BURNING SENSATION 5 0.0001
986 INTENTIONAL OVERDOSE 4 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
988 INJECTION SITE REACTION 4 0.0001
989 DRUG DEPENDENCE 9 0.0001
990 BREAST CANCER 5 0.0001
991 MYOCARDIAL INFARCTION 9 0.0001
992 TOXICITY TO VARIOUS AGENTS 7 0.0000
993 INJECTION SITE ERYTHEMA 5 0.0000
994 PSORIASIS 5 0.0000
995 INJECTION SITE PAIN 8 0.0000